Gene Therapy Market Growth and Development: Regional Demand, Segment by Types and End-User By 2035
Gene Therapy Market Size to Cross $16.5 Billion by 2035 | Exclusive Report by Roots Analysis
The global gene therapy market, valued at USD 2.4 billion in 2024, is estimated to reach USD 3.4 billion in 2025 and USD 16.5 billion by 2035, representing a CAGR of 17.0% during the forecast period.
Gene therapies are a class of biologic products designed to alter the genetic material of an individual to treat rare diseases caused by inherited genetic mutations. These therapies are developed to address the underlying genetic cause of a disease, either by introducing a healthy version of the mutated gene or by inactivating the functions of disease-causing genes within the body. Currently, 20 gene therapies are commercially available for the treatment of various genetic disorders, including spinal muscular atrophy and sickle cell disease. Additionally, more than 370 candidates are currently being evaluated across various phases of clinical trials and around 920 gene therapies are being developed across preclinical and discovery stages of development. Further, it is worth highlighting that these therapies have demonstrated tremendous potential in revolutionizing the treatment of chronic conditions, with promising results in achieving complete disease remission. As such, the demand for gene therapies is increasing substantially, thereby encouraging gene therapy companies and non-industry players to enhance their R&D capabilities in order to develop and advance a greater number of therapies towards the commercial market. Driven by the growing demand for targeted therapies, the gene therapy market size is poised to experience a noteworthy increase during the forecast period.
To request a sample copy / brochure of this report, please visit
https://www.rootsanalysis.com/....reports/gene-therapi
1 (877) 773-1002